Holen Sie sich die Stockscreener-App
12.71
2.52%
-0.3598
Finanzdaten der Intellia Therapeutics Inc-Aktie (NTLA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
14.33%
14.24
|
16.63 | 9.111 | 6.957 | 28.93 |
Operating Expenses
|
9.60%
124.24
|
137.43 | 153.88 | 146.00 | 142.94 |
| Benefits Costs and Expenses |
5.13%
124.24
|
130.96 | 153.88 | 146.00 | 136.37 |
| Costs And Expenses |
9.60%
124.24
|
137.43 | 153.88 | 146.00 | 142.94 |
| Operating Income/Loss |
8.95%
-110.00
|
-120.81 | -144.77 | -139.04 | -114.00 |
| Income/Loss From Continuing Operations Before Tax |
3.79%
-110.00
|
-114.33 | -144.77 | -146.97 | -107.44 |
| Income/Loss From Continuing Operations After Tax |
11.44%
-101.25
|
-114.33 | -135.71 | -146.97 | -107.44 |
|
Net Income/Loss
|
11.44%
-101.25
|
-114.33 | -135.71 | -146.97 | -107.44 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.22%
103.73
|
103.50 | 101.00 | 96.97 | 95.50 |
| Diluted Average Shares |
0.22%
103.73
|
103.50 | 101.00 | 96.97 | 95.50 |
| Basic Earnings Per Share |
10.91%
-0.98
|
-1.10 | -1.34 | -1.52 | -1.12 |
| Diluted Earnings Per Share |
10.91%
-0.98
|
-1.10 | -1.34 | -1.52 | -1.12 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.18%
0.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):